SYNTHESIS AND THIN-LAYER CHROMATOGRAPHIE, ULTRAVIOLET, AND MASS SPECTRAL PROPERTIES OF THE ANTICOAGULANT PHENPROCOUMON AND ITS MONOHYDROXYLATED DERIVATIESPOHL LR; HADDOCK R; GARLAND WA et al.1975; J. MEDICIN. CHEM.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 513-519; BIBL. 27 REF.Article

A clinical algorithm to predict the loading dose of phenprocoumonCADUFF GOOD, Angela; HENZ, Samuel.Thrombosis research. 2007, Vol 120, Num 6, pp 921-925, issn 0049-3848, 5 p.Article

Discontinuation of anticoagulant care during admission to a psychiatric hospitalABDULLAH-KOOLMEES, H; GERBRANDA, T; DENEER, V. H. M et al.European journal of clinical pharmacology. 2013, Vol 69, Num 4, pp 1025-1029, issn 0031-6970, 5 p.Article

LES LIAISONS DANGEREUSES. RIFAMPICINE ET ANTIVITAMINES KLABRAM C.1975; CONCOURS MED.; FR.; DA. 1975; VOL. 97; NO 13; PP. 2173-2174; BIBL. 4REF.Article

Dependency of phenprocoumon dosage on polymorphisms in the VKORC1, CYP2C9, and CYP4F2 genesTEICHERT, Martina; EIJGELSHEIM, Mark; UITTERLINDEN, Andre G et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 1, pp 26-34, issn 1744-6872, 9 p.Article

Invasive procedures in the outpatient setting : Managing the short-acting acenocoumarol and the long-acting phenprocoumonVAN GEEST-DAALDEROP, Johanna H. H; HUTTEN, Barbara A; PEQUERIAUX, Nathalie C. V et al.Thrombosis and haemostasis. 2007, Vol 98, Num 4, pp 747-755, issn 0340-6245, 9 p.Article

Phenprocoumon and acenocoumarol treatment in paediatric patientsSPOOR, Nienke; SMIERS, Frans J; VAN DER MEER, Felix J. M et al.Thrombosis and haemostasis. 2012, Vol 108, Num 6, pp 1238-1241, issn 0340-6245, 4 p.Article

Usefulness of Phenprocoumon for the Treatment of Obstructing Thrombus in Bioprostheses in the Aortic Valve PositionJANDER, Nikolaus; KIENZLE, Rolf-Peter; KAYSER, Gian et al.The American journal of cardiology. 2012, Vol 109, Num 2, pp 257-262, issn 0002-9149, 6 p.Article

Pregnancy outcome after maternal intoxication with phenprocoumonHAUCK, Barbara; ZIMMERMANN, Robert; RINGWALD, Juergen et al.British journal of clinical pharmacology. 2011, Vol 71, Num 1, pp 139-140, issn 0306-5251, 2 p.Article

Analysis of pooled plasma samples as a predictor for proving bioequivalence of drugs with a long elimination half-life the example of phenprocoumonGATCHEV, Emil; THYROFF-FRIESINGER, Ursula; BAKRACHEVA, Nina et al.Arzneimittel-Forschung. 2004, Vol 54, Num 10, pp 685-689, issn 0004-4172, 5 p.Article

Identification of cytochromes P₄₅₀ 2C9 and 3A4 as the major catalysts of phenprocoumon hydroxylation in vitroUFER, Mike; SVENSSON, Jan O; KRAUSZ, Kristopher W et al.European journal of clinical pharmacology. 2004, Vol 60, Num 3, pp 173-182, issn 0031-6970, 10 p.Article

Genetic determinants of acenocoumarol and phenprocoumon maintenance dose requirementsCADAMURO, Janne; DIEPLINGER, Benjamin; FELDER, Thomas et al.European journal of clinical pharmacology. 2010, Vol 66, Num 3, pp 253-260, issn 0031-6970, 8 p.Article

The influence on INRs and coagulation factors of the time span between blood sample collection and intake of phenprocoumon or acenocoumarol : Consequences for the assessment of the doseVAN GEEST-DAALDEROP, Johanna H. H; HUTTEN, Barbara A; PEQUERIAUX, Nathalie C. V et al.Thrombosis and haemostasis. 2007, Vol 98, Num 4, pp 738-746, issn 0340-6245, 9 p.Article

Obesity is associated with a slower response to initial phenprocoumon therapy whereas CYP2C9 genotypes are notZU SCHWABEDISSEN, Cordula Meyer; MEVISSEN, Vera; SCHMITZ, Fabian et al.European journal of clinical pharmacology. 2006, Vol 62, Num 9, pp 713-720, issn 0031-6970, 8 p.Article

Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumonFIHN, Stephan D; GADISSEUR, Alain A. P; HARDERMAN, Derk et al.Thrombosis and haemostasis. 2003, Vol 90, Num 2, pp 260-266, issn 0340-6245, 7 p.Article

The effect of oral anticoagulation on clotting during hemodialysisZIAI, Farzad; BENESCH, Thomas; KODRAS, Katharina et al.Kidney international. 2005, Vol 68, Num 2, pp 862-866, issn 0085-2538, 5 p.Article

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic dataVAN SCHIE, Rianne M. F; WESSELS, Judith A. M; LE CESSIE, Saskia et al.European heart journal. 2011, Vol 32, Num 15, pp 1909-1917, issn 0195-668X, 9 p.Article

Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failureSCHIMANSKI, Carl C; BURG, Jürgen; MÖHLER, Markus et al.Journal of hepatology. 2004, Vol 41, Num 1, pp 67-74, issn 0168-8278, 8 p.Article

Oral anticoagulation with coumarin derivatives and antiptatetet effects of clopidogrelSIBBING, Dirk; VON BECKERATH, Nicolas; MORATH, Tanja et al.European heart journal. 2010, Vol 31, Num 10, pp 1205-1211, issn 0195-668X, 7 p.Article

Diffuse alveolar hemorrhage with acute respiratory distress syndrome associated with phenprocoumon therapyKLENNER, Anne F; FRIESECKE, Sigrun; SCHÄPER, Christoph et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 8, pp 813-815, issn 0957-5235, 3 p.Article

Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumonVISSER, Loes E; PENNING-VAN BEEST, Fernie J. A; WILSON, J. H. P et al.British journal of clinical pharmacology. 2004, Vol 57, Num 4, pp 522-524, issn 0306-5251, 3 p.Article

Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteersKIRCHHEINER, Julia; UFER, Mike; BROCKMÖLLER, Jürgen et al.Pharmacogenetics (London). 2004, Vol 14, Num 1, pp 19-26, issn 0960-314X, 8 p.Article

Phenprocoumon-induced hepatitis as an immunologically mediated drug allergic complication of antithrombotic therapyDORN-BEINEKE, Alexandra; HASSAN, Abdul-Wahab; BRÄUTIGAM, Joachim et al.Thrombosis and haemostasis. 2003, Vol 90, Num 6, pp 1210-1213, issn 0340-6245, 4 p.Article

The relationship between maintenance dosages of three vitamin K antagonists : Acenocoumarol, warfarin and phenprocoumonVAN LEEUWEN, Yvonne; ROSENDAAL, Frits R; VAN DER MEER, Felix. J. M et al.Thrombosis research. 2008, Vol 123, Num 2, pp 225-230, issn 0049-3848, 6 p.Article

A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and PhenprocoumonVERHOEF, Talitha I; RAGIA, Georgia; REDEKOP, William K et al.The New England journal of medicine. 2013, Vol 369, Num 24, pp 2304-2312, issn 0028-4793, 9 p.Article